Comparative Assessment of Two Strategies for Interpreting Tumor Markers in Ascitic Effusions

In Vivo. 2020 Mar-Apr;34(2):715-722. doi: 10.21873/invivo.11829.

Abstract

Background/aim: There are two strategies for the interpretation of tumor markers (TM) in fluid effusions: i) high cut-off and ii) fluid/serum ratio (F/S) and low cut-off. The objective of this study is to compare these two strategies and to determine whether diagnostic accuracy improves by the identification of possible false positives using Adenosine deaminase (ADA), C reactive protein (CRP) and % of polymorphonuclear cells (%PN).

Patients and methods: We studied 157 ascitic fluids, 74 of which were malignant. ADA, CRP and %PN were determined in ascitic fluid, and Carcinoembryonic antigen (CEA), Cancer antigen 72-4 (CA72-4), Cancer antigen CA19-9 and Cancer antigen 15-3 (CA15-3) in both fluid and serum.

Results: The strategy of high cut-off showed 59.5% sensitivity at 100% specificity. The F/S strategy showed 75.7% sensitivity at 95.2% specificity. Subclassifying cases with ADA, CRP and %PN negative showed 67.5% sensitivity at 100% specificity for high cut-off and for the F/S strategy was 81.7% sensitivity at 98.7% specificity.

Conclusion: The strategy of F/S with negative ADA, CRP and %PN allow the best interpretation for TM in the ascitic fluid.

Keywords: Diagnosis; cancer; differential diagnosis; malignant ascites; tumour markers.

Publication types

  • Comparative Study

MeSH terms

  • Adenosine Deaminase / metabolism
  • Adult
  • Aged
  • Aged, 80 and over
  • Antigens, Tumor-Associated, Carbohydrate / metabolism
  • Ascitic Fluid / chemistry
  • Ascitic Fluid / metabolism*
  • Biomarkers, Tumor / analysis
  • Biomarkers, Tumor / blood*
  • C-Reactive Protein / metabolism
  • CA-19-9 Antigen / metabolism
  • Carcinoembryonic Antigen / metabolism
  • Diagnosis, Differential
  • Female
  • Humans
  • Male
  • Middle Aged
  • Mucin-1 / metabolism
  • Neoplasms / blood*
  • Neoplasms / diagnosis
  • Neoplasms / metabolism
  • Neutrophils / pathology
  • Sensitivity and Specificity

Substances

  • Antigens, Tumor-Associated, Carbohydrate
  • Biomarkers, Tumor
  • CA-19-9 Antigen
  • CA-72-4 antigen
  • Carcinoembryonic Antigen
  • MUC1 protein, human
  • Mucin-1
  • C-Reactive Protein
  • Adenosine Deaminase